CALIFORNIA GRAPES INTL INC
OOTC:CAGRCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Jeffrey Crittenden
- Full Time Employees
- - -
- Sector
- Consumer durables
- Industry
- Automotive aftermarket
- Address
- 2360 Corporate Circle Henderson NV United States 89074-7722
- IPO Date
- Jun 10, 2008
- Website
- cagrapes.com
- Similar Companies
- Business
- California Grapes International, Inc. California Grapes International, Inc. operates as a full-service export sales, marketing, promotions, education, and distribution company focused on California wines and American wines internationally. The company purchases wines directly from U.S. manufacturers and distributes them to distributors, grocery stores, supermarkets, hypermarkets, consumers, restaurants, and hotel venues, with particular emphasis on markets in China and other nations; it also provides specialized services for exporting, marketing, promoting, distributing, and selling products within the California wine industry, including through subsidiaries engaged in importation and distribution in China. Headquartered in Henderson, Nevada, with additional offices in Beijing, China, California Grapes International, Inc. was founded in 1992, originally incorporated in Florida before re-domiciling to Nevada in 2011, and conducts operations primarily in the consumer defensive sector's food distribution industry, targeting international markets for premium American beverages such as wines and distilled spirits. Recent financial disclosures indicate trailing twelve-month revenue of approximately $806,000 and a market capitalization of around $1,560 as of mid-2025, reflecting its niche positioning amid limited public updates on major strategic shifts, partnerships, acquisitions, or new product launches within the last 1-2 years.
Company News
Koninklijke KPN: Why I Expect A 25% Dividend Increase In 2027
Caliway Announces Positive Phase 2 Results of CBL-514 in Dercum's Disease, Achieving Primary Endpoint with Statistically Significant and Sustained Pain Reduction
On Holding (ONON) Sets Ambitious 2029 Goals with Share Buyback Announcement
TASE Presents 2027-2031 Strategic Plan to Accelerate Revenue Growth, Expand International Activity and Create Long-Term Shareholder Value Targets 15%-18% Revenue CAGR
TASE Presents 2027-2031 Strategic Plan to Accelerate Revenue Growth, Expand International Activity and Create Long-Term Shareholder Value Targets 15%-18% Revenue CAGR
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
Mech-Mind Launches IPO: Baillie Gifford Leads 9 Top Cornerstone Investors, HK$2.7B for AI R&D & Global Commercialization
L3Harris: Missile Solutions To Drive Growth, IPO As The Next Catalyst
Logistics Division Hyper-Growth (+80% CAGR) Unlocks Multi-Year Run Rate — Accelerating CLIK's High-Margin Care U Expansion & Strategic Spin-Off
Shenzhen HQVT Technology Lists on HKEX Main Board, Accelerating Implementation of Multispectral AI Technology
Wellgistics Health and Datavault AI to Form DelivMeds AI via PharmacyChain™ License Expansion and Acquisitions of QOLPOM Biometric Health Data and Drone Logistics IP and Majority of Tollo Health
Circle Internet Group (CRCL) Reports Strong Q1 with Increased USDC Adoption
TSMC Expects AI Chip Revenue to Grow at a 60% CAGR Through 2029. Is the Stock a Buy for 2026?
Amadeus IT Group: Overblown Fears Of AI Create A Huge Buy Opportunity
Philip Morris: Tobacco King Is Overbought - Wait For Dip Buying Opportunity
Sensor Patch Market Accelerates at 29.8% CAGR, Targeting USD 34.9 Billion by 2032 on Rising Wearable Health Adoption and Real-Time Vital Monitoring: AnalystView Market Insights
Circle CEO Jeremy Allaire on stablecoins: A CAGR of 40% is a pretty reasonable baseline
TSMC: Why I'm Downgrading After The Company's Best Quarter Ever
Why Poly-Woven Packaging Market Manufacturers are Successful
Pharmaceutical Waste Management Market is expected to generate a revenue of USD 2631.59 Million by 2032, Globally, at 5.91% CAGR: Verified Market Research®